Veeva(US:VEEV) ZACKSยท2025-07-17 22:45Company Performance - Veeva Systems (VEEV) shares decreased by 2.13% to $276.46, underperforming the S&P 500's daily gain of 0.54% [1] - Over the past month, Veeva's shares increased by 0.37%, outperforming the Medical sector's decline of 2.12% but lagging behind the S&P 500's rise of 4.2% [1] Upcoming Earnings - Veeva Systems is expected to report an EPS of $1.9, reflecting a 17.28% increase year-over-year [2] - The projected revenue for the upcoming earnings is $767.61 million, which is a 13.52% increase compared to the same quarter last year [2] Full-Year Estimates - The full-year Zacks Consensus Estimates predict earnings of $7.64 per share and revenue of $3.1 billion, indicating year-over-year growth of 15.76% and 12.78%, respectively [3] - Recent changes in analyst estimates suggest positive sentiment towards Veeva's business operations and profit generation capabilities [3] Zacks Rank and Valuation - Veeva Systems currently holds a Zacks Rank of 2 (Buy), with the consensus EPS estimate increasing by 0.6% over the last 30 days [5] - The company has a Forward P/E ratio of 36.95, which is higher than the industry average of 28.78, and a PEG ratio of 1.59, compared to the Medical Info Systems industry's average PEG ratio of 3.29 [6] Industry Context - The Medical Info Systems industry, part of the Medical sector, has a Zacks Industry Rank of 83, placing it in the top 34% of over 250 industries [7] - Research indicates that industries in the top 50% outperform those in the bottom half by a factor of 2 to 1 [7]